Financial results to be released after
market close; Conference call to be conducted at 5:00 pm ET
PHOENIX, May 2, 2024
/PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report
financial results for its first quarter 2024, ended March 31, 2024, after the market close on
Thursday, May 9, 2024. The Company
has scheduled a conference call that same day, Thursday, May 9, 2024, at 5:00 pm ET, to review the results.
First Quarter 2024 Conference Call Details
Date and Time: Thursday, May 9,
2024, at 5:00 pm ET
Call-in Information: Interested parties can access the
conference call by dialing (844) 308-3351 or (412) 317-5407.
Live Webcast Information: Interested parties can access
the conference call via a live webcast, which is available in the
Investor Relations section of the Company's website at
https://app.webinar.net/1B350eDkK4R or
http://senestech.investorroom.com/.
Replay: A teleconference replay of the call will be
available for seven days at (877) 344-7529 or (412) 317-0088,
replay access code 2801164. A webcast replay will be available in
the Investor Relations section of the Company's website at
http://senestech.investorroom.com/ for 90 days.
About SenesTech
We are committed to improving the
health of the world by humanely managing animal pest populations
through our expertise in fertility control. We invented ContraPest,
the only U.S. EPA-registered contraceptive for male and female
rats, as well as Evolve and Evolve Mouse, EPA-designated minimum
risk contraceptives for rodents, reflecting our mission to provide
products that are proactive, safe and sustainable. ContraPest and
Evolve fit seamlessly into all integrated pest management programs,
significantly improving the overall goal of effective pest
management. We strive for clean cities, efficient businesses and
happy households – with a product designed to be humane, effective
and sustainable.
For more information visit https://senestech.com/.
Safe Harbor Statement
Forward-looking statements include statements concerning results
of operations and financial performance; the Company's strategy and
target marketing and markets; continuing the Company's vision;
expected benefits of the Company's initiatives and continuation of
those initiatives; deployment of the Company's product; the
continuation or expansion of the use of ContraPest; demand for
ContraPest; the Company's expectation regarding costs, expenses and
cash and continuing its cost improvement plan; future financial
results; and the Company's execution of its strategic business
plan.
CONTACT:
Investor: Robert Blum, Lytham
Partners, LLC, 602-889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief
Financial Officer, SenesTech, Inc., 928-779-4143
View original content to download
multimedia:https://www.prnewswire.com/news-releases/senestech-to-report-first-quarter-2024-financial-results-on-thursday-may-9-2024-302134925.html
SOURCE SenesTech, Inc.